title: Successful long-term treatment of TMA with eculizumab in a transplanted patient with atypical hemolytic uremic syndrome due to MCP mutation.
authors.affiliation: 1 Department of Internal Medicine D, General Internal Medicine and Nephrology, University Hospital Münster, Münster, Germany 2 Gerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Reuter
authors.forename: Barbara
authors.initials: B
authors.lastname: Heitplatz
authors.forename: Hermann
authors.initials: H
authors.lastname: Pavenstädt
authors.forename: Barbara
authors.initials: B
authors.lastname: Suwelack
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D001706:Biopsy; D004247:DNA / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006463:Hemolytic-Uremic Syndrome / Q000235:genetics / Q000601:surgery*; D006801:Humans; D016030:Kidney Transplantation; D051916:Membrane Cofactor Protein / Q000235:genetics*; D009154:Mutation; D057049:Thrombotic Microangiopathies / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C497857:CD46 protein, human; D051916:Membrane Cofactor Protein; D004247:DNA; C481642:eculizumab